Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 6 TEVA PHARMACEUTICALS USA, INC., Case No. 24-cv-03567-BLF
Plaintiff, ORDER DENYING DEFENDANTS' v. ADMINISTRATIVE MOTION TO
CONTINUE INITIAL CASE
CORCEPT THERAPEUTICS, INC., et al., MANAGEMENT CONFERENCE Defendants. [Re: ECF No. 43]
12 On August 26, 2024, Defendants filed motions to dismiss the complaint and motions to stay discovery pending the resolution of the motions to dismiss. ECF 34, 35, 36, 37. The motions to dismiss and motions to stay discovery were terminated as moot in light of Plaintiff’s amended complaint filed on September 13. ECF 39, 40. The Initial Case Management Conference for this 16 case is set for October 31, 2024. ECF 14. Accordingly, the deadline for the parties’ initial Rule 26(f) 17 conference is October 10, 2024. Id.; see Fed. R. Civ. P. 26(f)(1). Before the Court is Defendants’ 18 administrative motion to continue case management conference. ECF 43. Defendants argue that an 19…